The Concentration-dependent Investigation of the Toxic Effects of the Anorectic Agent Sibutramine on the Electrical Activity of the Cardiomyocytes in Metabolic Syndrome Rat Heart
Abstract
Objectives: Sibutramine (SBT) has been intensely used for losing weight over the past decades. In addition to the known mode of its action through brown adipose tissue thermogenesis, systemic actions reveal some side effects including alterations in cardiac function. Despite various clinical findings, the effect of SBT on cellular levels remains elusive. This study aimed to investigate the possible effects of sibutramine on the electrical activity of the cardiomyocytes from freshly isolated metabolic syndrome (MetS) rat hearts.
Materials and Methods: Wistar type 2-month-old male rats were used. The animals were fed (20-22 weeks) with tap water containing 32% sucrose in addition to standard feed (20-22 weeks). MetS were confirmed using higher body weight, higher fasting blood glucose, and impaired glucose tolerance test. Heart tissue sections were stained with Masson Trichrome and examined under light microscopy. All patch-clamp experiments were performed in whole-cell mode, but action potentials were recorded in current-clamp configuration and voltage-gated K+-channel currents in voltage-clamp configuration from freshly isolated MetS cardiomyocytes. Acute SBT treatment was performed in a concentration-dependent manner (10-8-10-5 M) for all cardiomyocytes.
Results: Histological examinations reveal that MetS hearts are characterized by a marked increase in collagen depositions. Electrophysiological findings show the significant prolongation in action potential duration, indicate pro-arrhythmic action for SBT treatment in a concentrationdependent manner. As voltage-gated K+-channel currents (IK) are responsible for changes in the repolarization of the action potentials (AP) in ventricular cardiomyocytes acute SBT treatment reduced IK channels significantly.
Conclusion: This study showed that the effects of SBT on prolongation of action potential and reduction in IK channel density include proarrhythmic and detrimental outcomes in overweighed MetS hearts.
Keywords
Sibutramine, Electrical Activity, Action Potential, K+- Current, Obesity, Metabolic Syndrome
Ethical Statement
Etik Kurul Onayı: Ankara Üniversitesi Hayvan Deneyleri
Yerel Etik Kurulu’ndan onay alınmıytır (no: 2015-10-125).
Hasta Onayı: Bu çalışmada hayvan deneyi olduğundan,
hasta onayı alınmamıştır.
Hakem Değerlendirmesi: Editörler kurulunun dışından ve
içinden olan kişiler tarafından değerlendirilmiştir
References
- 1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
- 2. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome. Lancet. 2005;366:1921-1922.
- 3. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
- 4. Chinali M, de Simone G, Roman MJ, et al. Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol. 2008;52:932-938.
- 5. Zannad F, Gille B, Grentzinger A, et al. Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction. Am Heart J. 2002;144:508-515.
- 6. Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol (1985). 2005;99:1193-1204.
- 7. Sullivan PW, Ghushchyan V, Wyatt HR, et al. Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity (Silver Spring). 2007;15:511-521.
- 8. Balkau B, Deanfield JE, Després JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007;116:1942-1951.
- 9. Cannon CP, Kumar A. Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Clin Cornerstone. 2009;9:55-68.
- 10. Whaley-Connell A, Sowers JR, McCullough PA, et al. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis. 2009;53:11-21.